Cross-over, Double-blind, Unicentric, 52 Week Trial of Liraglutide in Type 1 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIDO
- 05 Dec 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 17 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.